Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
Johnson and Johnson
Cipla
Chubb
Colorcon
Federal Trade Commission
US Army
Mallinckrodt
AstraZeneca
Harvard Business School

Generated: October 18, 2017

DrugPatentWatch Database Preview

MORPHINE SULFATE Drug Profile

« Back to Dashboard

Which patents cover Morphine Sulfate, and what generic Morphine Sulfate alternatives are available?

Morphine Sulfate is a drug marketed by Novel Labs Inc, Upsher-smith Labs, Dava Pharms Inc, West-ward Pharms Int, Rhodes Pharms, Hospira, Hi-tech Pharmacal, Vintage Pharms Llc, Impax Labs Inc, Nostrum Labs Inc, Par Pharm Inc, Mallinckrodt, Hospira Inc, Icu Medical Inc, Lannett Holdings Inc, Teva Pharms Usa, Tris Pharma Inc, Nesher Pharms, Fresenius Kabi Usa, Mylan Pharms Inc, Mallinckrodt Inc, Sun Pharm Inds, Actavis Elizabeth, Vistapharm, Watson Labs, Epic Pharma Llc, Eurohlth Intl Sarl, Sun Pharm Inds Ltd, Pharm Assoc, Paddock Llc, Mayne Pharma Inc, and Meridian Medcl Techn. and is included in fifty-three NDAs. There are three patents protecting this drug.

This drug has fifteen patent family members in seven countries.

The generic ingredient in MORPHINE SULFATE is morphine sulfate. There are twenty-three drug master file entries for this compound. Fifty-four suppliers are listed for this compound. Additional details are available on the morphine sulfate profile page.

Summary for Tradename: MORPHINE SULFATE

US Patents:3
Applicants:32
NDAs:53
Suppliers / Packagers: see list47
Bulk Api Vendors: see list16
Clinical Trials: see list1,714
Patent Applications: see list9,796
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:MORPHINE SULFATE at DailyMed

Pharmacology for Tradename: MORPHINE SULFATE

Drug ClassOpioid Agonist
Mechanism of ActionFull Opioid Agonists
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Elizabeth
MORPHINE SULFATE
morphine sulfate
CAPSULE, EXTENDED RELEASE;ORAL079040-004Jan 16, 2013RXNoNo► Subscribe► Subscribe► Subscribe
Hospira Inc
MORPHINE SULFATE
morphine sulfate
INJECTABLE;INJECTION202515-002Nov 14, 2011APRXYesYes► Subscribe► Subscribe► Subscribe
Par Pharm Inc
MORPHINE SULFATE
morphine sulfate
CAPSULE, EXTENDED RELEASE;ORAL200812-002Nov 10, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe
Mylan Pharms Inc
MORPHINE SULFATE
morphine sulfate
TABLET, EXTENDED RELEASE;ORAL200824-004Oct 18, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe
Nostrum Labs Inc
MORPHINE SULFATE
morphine sulfate
SOLUTION;ORAL204053-001Oct 6, 2016AARXNoNo► Subscribe► Subscribe► Subscribe
Watson Labs
MORPHINE SULFATE
morphine sulfate
INJECTABLE;INJECTION073376-001Sep 30, 1991DISCNNoNo► Subscribe► Subscribe► Subscribe
Teva Pharms Usa
MORPHINE SULFATE
morphine sulfate
CAPSULE, EXTENDED RELEASE;ORAL202718-001Dec 29, 2014ABRXNoNo► Subscribe► Subscribe► Subscribe
Actavis Elizabeth
MORPHINE SULFATE
morphine sulfate
TABLET, EXTENDED RELEASE;ORAL203849-004Apr 6, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Rhodes Pharms
MORPHINE SULFATE
morphine sulfate
SOLUTION;ORAL206420-001Jul 12, 2016AARXNoNo► Subscribe► Subscribe► Subscribe
Icu Medical Inc
MORPHINE SULFATE
morphine sulfate
INJECTABLE;INJECTION019916-001Oct 30, 1992APRXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Tradename: MORPHINE SULFATE

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
9,545,473Packaging system for oxygen-sensitive drugs► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: MORPHINE SULFATE

Country Document Number Estimated Expiration
World Intellectual Property Organization (WIPO)2014140095► Subscribe
European Patent Office3143988► Subscribe
Hong Kong1208015► Subscribe
Canada2902346► Subscribe
European Patent Office2968132► Subscribe
Australia2014230836► Subscribe
Japan2016512455► Subscribe
China104528165► Subscribe
European Patent Office2968729► Subscribe
China204798475► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim
Teva
Merck
Farmers Insurance
Chubb
Express Scripts
Covington
Cipla
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot